The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Cell Death in Liver Diseases: A Review
Open accessAbstract
Regulated cell death (RCD) is pivotal in directing the severity and outcome of liver injury. Hepatocyte cell death is a critical event in the progression of liver disease due to resultant inflammation leading to fibrosis. Apoptosis, necrosis, necroptosis, autophagy, and recently, pyroptosis and ferroptosis, have all been investigated in the pathogenesis of various liver diseases. These cell death subroutines display distinct features, while sharing many similar characteristics with considerable overlap and crosstalk. Multiple types of cell death modes can likely coexist, and the death of different liver cell populations may contribute to liver injury in each type of disease. This review addresses the known signaling cascades in each cell death pathway and its implications in liver disease. In this review, we describe the common findings in each disease model, as well as the controversies and the limitations of current data with a particular focus on cell death-related research in humans and in rodent models of alcoholic liver disease, non-alcoholic fatty liver disease and steatohepatitis (NASH/NAFLD), acetaminophen (APAP)-induced hepatotoxicity, autoimmune hepatitis, cholestatic liver disease, and viral hepatitis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–270 of 270
You, Y., Li, W., Zhang, S., Hu, B., Li, Y., Li, H., Tang, H., Li, Q., Guan, Y., Liu, L., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.01.038 · Cited by 93
Apoptotic pathways in primary biliary cirrhosis and autoimmune hepatitis
Fox, C. K., Furtwaengler, A., Nepomuceno, R. R., Martinez, O. M., & Krams, S. M. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.021004272.x · Cited by 91
Wang, S., Ni, H., Dorko, K., Kumer, S. C., Schmitt, T. M., Nawabi, A. M., Komatsu, M., Huang, H., & Ding, W. (2016) · Oncotarget · doi:10.18632/oncotarget.6893 · Cited by 91
Knight, T. R., & Jaeschke, H. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9407 · Cited by 90
Caspases in metabolic disease and their therapeutic potential
Wilson, C. H., & Kumar, S. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0111-x · Cited by 89
Valenti, L. V. C., Moscatiello, S., Vanni, E., Fracanzani, A. L., Bugianesi, E., Fargion, S. R., & Marchesini, G. (2010) · QJM · doi:10.1093/qjmed/hcq170 · Cited by 87
Chen, D., Ni, H., Wang, L., Ma, X., Yu, J., Ding, W., & Zhang, L. (2018) · Hepatology · doi:10.1002/hep.30422 · Cited by 87
Protective Effects of Necrostatin-1 against Concanavalin A-Induced Acute Hepatic Injury in Mice
Zhou, Y., Dai, W., Lin, C., Wang, F., He, L., Shen, M., Chen, P., Wang, C., Lu, J., Xu, L., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/706156 · Cited by 85
The Inflammasome in Liver Injury and Non-Alcoholic Fatty Liver Disease
Mehal, W. Z. (2014) · Digestive Diseases · doi:10.1159/000360495 · Cited by 83
RIPK1 protects from TNF-α-mediated liver damage during hepatitis
Filliol, A. A., Piquet‐Pellorce, C., Seyec, J. L., Farooq, M., Genêt, V., Lucas‐Clerc, C., Bertin, J., Gough, P. J., Dimanche‐Boitrel, M., Vandenabeele, P., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.362 · Cited by 83
Roychowdhury, S., Chiang, D. J., Mandal, P., McMullen, M. R., Liu, X., Cohen, J. I., Pollard, J. R., Feldstein, A. E., & Nagy, L. E. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01720.x · Cited by 82
Treating Acute Acetaminophen Poisoning With Acetylcysteine
Peterson, R. G. (1977) · JAMA · doi:10.1001/jama.1977.03270490046025 · Cited by 81
Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids
Woolbright, B. L., & Jaeschke, H. (2019) · Gene Expression · doi:10.3727/105221619x15614873062730 · Cited by 74
Activated MLKL attenuates autophagy following its translocation to intracellular membranes
Frank, D. O., Vaux, D. L., Murphy, J. M., Vince, J. E., & Lindqvist, L. (2019) · Journal of Cell Science · doi:10.1242/jcs.220996 · Cited by 72
Rashed, M. S., Myers, T. G., & Nelson, S. D. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08649-0 · Cited by 71
The role of MAP2 kinases and p38 kinase in acute murine liver injury models
Zhang, J., Min, R. W. M., Le, K., Zhou, S., Aghajan, M., Than, T. A., Win, S., & Kaplowitz, N. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.295 · Cited by 71
Zeng, T., Deng, G., Zhong, W., Gao, Z., Ma, S., Mo, C., Li, Y., Huang, S., Zhou, C., Lai, Y., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.01.009 · Cited by 71
Zhou, Z., Ye, T. J., Bonavita, G. J., Daniels, M., Kainrad, N., Jogasuria, A. P., & You, M. (2019) · Hepatology Communications · doi:10.1002/hep4.1333 · Cited by 70
Prevention of acetaminophen-induced hepatotoxicity by dimethyl sulfoxide
Park, Y. H., Smith, R. D., Combs, A. B., & Kehrer, J. P. (1988) · Toxicology · doi:10.1016/0300-483x(88)90202-8 · Cited by 69
Deferoxamine delays the development of the hepatotoxicity of acetaminophen in mice
Schnellmann, J. G., Pumford, N. R., Kusewitt, D. F., Bucci, T. J., & Hinson, J. A. (1999) · Toxicology Letters · doi:10.1016/s0378-4274(99)00021-1 · Cited by 68
Skeldon, A. M., & Saleh, M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00015 · Cited by 68
Cyclophilin D deficiency attenuates mitochondrial perturbation and ameliorates hepatic steatosis
Wang, X., Du, H., Shao, S., Bo, T., Yu, C., Chen, W., Zhao, L., Li, Q., Wang, L., Liu, X., et al. (2018) · Hepatology · doi:10.1002/hep.29788 · Cited by 68
Targeting Pink1-Parkin-mediated mitophagy for treating liver injury
Williams, J. A. R., & Ding, W. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.09.020 · Cited by 67
Role of autophagy in alcohol and drug-induced liver injury
Williams, J. A. R., & Ding, W. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.111075 · Cited by 67
Filliol, A. A., Piquet‐Pellorce, C., Raguénès‐Nicol, C., Dion, S., Farooq, M., Lucas‐Clerc, C., Vandenabeele, P., Bertrand, M. J. M., Seyec, J. L., & Samson, M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.005 · Cited by 66
TNF superfamily receptor OX40 triggers invariant NKT cell pyroptosis and liver injury
Lan, P., Fan, Y., Zhao, Y., Lou, X., Monsour, H., Zhang, X., Choi, Y., Dou, Y., Ishii, N., Ghobrial, R. M., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91075 · Cited by 65
Suda, J., Dara, L., Yang, L., Aghajan, M., Song, Y., Kaplowitz, N., & Liu, Z. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600690 · Cited by 63
Self-citationMaroni, L., Agostinelli, L., Saccomanno, S., Pinto, C., Giordano, D. M., Rychlicki, C., Minicis, S. D., Trozzi, L., Bañales, J. M., Melum, E., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.10.010 · Cited by 61
TNFα sensitizes hepatocytes to FasL-induced apoptosis by NFκB-mediated Fas upregulation
Faletti, L. E., Peintner, L., Neumann, S., Sandler, S., Grabinger, T., Nelly, S. M., Merfort, I., Huang, C., Tschaharganeh, D. F., Kang, T.-W., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0935-9 · Cited by 60
Post-translational control of RIPK3 and MLKL mediated necroptotic cell death
Murphy, J. M., & Vince, J. E. (2015) · F1000Research · doi:10.12688/f1000research.7046.1 · Cited by 59
Lysosomal Cholesterol Accumulation Sensitizes To Acetaminophen Hepatotoxicity by Impairing Mitophagy
Baulies, A., Ribas, V., Núñez, S., Torres, S., Alarcón‐Vila, C., Martínez-Gili, L., Suda, J., Ybanez, M. D., Kaplowitz, N., García‐Ruiz, C., et al. (2015) · Scientific Reports · doi:10.1038/srep18017 · Cited by 59
Stress Signaling in the Methionine-Choline–Deficient Model of Murine Fatty Liver Disease
Soon, R. K., Yan, J. S., Grenert, J. P., & Maher, J. J. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.046 · Cited by 58
Hu, B., & Colletti, L. M. (2010) · Hepatology · doi:10.1002/hep.23715 · Cited by 56
Roh, Y. S., Kim, J. W., Park, S., Shon, C., Kim, S., Eo, S. K., Kwon, J. K., Lim, C. W., & Kim, B. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.07.011 · Cited by 55
Hao, F., Cubero, F. J., Ramadori, P., Liao, L., Haas, U., Lambertz, D., Sonntag, R., Bangen, J., Gaßler, N., Hoß, M., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.532 · Cited by 55
Gasdermin D protects against noninfectious liver injury by regulating apoptosis and necroptosis
Yang, C., Sun, P., Deng, M., Loughran, P., Li, W., Yi, Z., Li, S., Zhang, X., Fan, J., Billiar, T. R., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1719-6 · Cited by 54
Gasdermin E-derived caspase-3 inhibitors effectively protect mice from acute hepatic failure
Xu, W., Zhang, Q., Ding, C., Sun, H., Che, Y., Huang, H., Wang, Y., Wu, J., Hao, H., & Cao, L. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0434-2 · Cited by 54
No evidence for caspase-dependent apoptosis in acetaminophen hepatotoxicity
Jaeschke, H., Williams, C. D., & Farhood, A. I. (2010) · Hepatology · doi:10.1002/hep.23940 · Cited by 53
Toubi, E., Kessel, A., Goldstein, L., Slobodin, G., Sabo, E., Shmuel, Z., & Zuckerman, E. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00207-0 · Cited by 53
Naveau, S., Émilie, D., Balian, A., Grangeot‐Keros, L., Borotto, E., Portier, A., Giraud, V., Capron, F., Galanaud, P., & Chaput, J. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80227-4 · Cited by 53
Kuo, J., Bobardt, M. D., Chatterji, U., Mayo, P., Trepanier, D. J., Foster, R. T., Gallay, P. A., & Ure, D. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.261099 · Cited by 53
Luo, K. X., Zhu, Y. ‐., Zhang, L. ‐., He, H., Wang, X. ‐., & Zhang, L. (1997) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1997.00053.x · Cited by 52
Targeting Apoptosis in Autoimmune Hepatitis
Czaja, A. J. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3284-2 · Cited by 51
The Receptor Interacting Protein Kinases in the Liver
Dara, L. (2018) · Seminars in Liver Disease · doi:10.1055/s-0038-1629924 · Cited by 46
Self-citationCsák, T., Dolganiuc, A., Kodys, K., Nath, B., Petrášek, J., Bala, S., Lippai, D., & Szabó, G. (2011) · Hepatology · doi:10.1002/hep.24301 · Cited by 45
Li, H., Zhao, X., Cheng, Y., Zhang, Q., Wu, J. T., Lu, S., Zhang, W., Liu, Y., Zhou, M., Wang, Y., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i44.6527 · Cited by 45
Lambert, J. C., Zhou, Z., & Kang, Y. J. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800411 · Cited by 44
Ehrmann, J., Galuszková, D., Ehrmann, J., Krè, I., Jezdínská, V., Ek, B. V., Murray, P. G., & Koláø, Z. (2000) · Pathology & Oncology Research · doi:10.1007/bf03032363 · Cited by 44
Flow cytometric analysis of vesicular pH in rat hepatocytes after ethanol administration
Kharbanda, K. K., McVicker, D. L., Zetterman, R. K., MacDonald, R. G., & Donohue, T. M. (1997) · Hepatology · doi:10.1002/hep.510260419 · Cited by 43
Arshad, M. I., Piquet‐Pellorce, C., Filliol, A. A., L’Helgoualc’h, A., Lucas‐Clerc, C., Jouan-Lanhouet, S., Dimanche‐Boitrel, M., & Samson, M. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1270-6 · Cited by 39
Azad, A. I., Krishnan, A., Troop, L., Li, Y., Katsumi, T., Pavelko, K. D., Kostallari, E., Guicciardi, M. E., & Gores, G. J. (2020) · Hepatology · doi:10.1002/hep.31211 · Cited by 39
Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis
Farooq, M., Filliol, A. A., Eugénio, M. S., Piquet‐Pellorce, C., Dion, S., Raguénès‐Nicol, C., Jan, A., Dimanche‐Boitrel, M., Seyec, J. L., & Samson, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1277-3 · Cited by 37
Targeting signal transduction pathways which regulate necrosis in acetaminophen hepatotoxicity
Kaplowitz, N., Win, S., Than, T. A., Liu, Z., & Dara, L. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.050 · Cited by 33
Self-citationThe Activation and Function of Autophagy in Alcoholic Liver Disease
Khambu, B., Wang, L., Zhang, H., & Yin, X. (2017) · Current Molecular Pharmacology · doi:10.2174/1874467208666150817112654 · Cited by 28
Not All Mice Are the Same: Standardization of Animal Research Data Presentation
Omary, M. B., Cohen, D. E., El-Omar, E. M., Jalan, R., Low, M. J., Nathanson, M. H., Peek, R. M., & Turner, J. R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.034 · Cited by 24
Cubero, F. J., Peng, J., Liao, L., Su, H., Zhao, G., Zoubek, M. E., Macías‐Rodríguez, R. U., Ruiz‐Margáin, A., Reißing, J., Zimmermann, H. W., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.08.015 · Cited by 24
Role of ferroptosis in acetaminophen-induced hepatotoxicity
Yamada, N., Karasawa, T., & Takahashi, M. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02714-5 · Cited by 24
A murder mystery in the liver: who done it and how?
Dara, L., Liu, Z., & Kaplowitz, N. (2016) · Journal of Clinical Investigation · doi:10.1172/jci90830 · Cited by 22
Self-citationCiccaglione, A. R., Marcantonio, C., Costantino, A., Equestre, M., & Rapicetta, M. (2003) · Intervirology · doi:10.1159/000069747 · Cited by 20
Hu, C., Zhao, L., Shen, M., Wu, Z., & Li, L. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15565 · Cited by 19
RIPK1 protects hepatocytes from death in Fas-induced hepatitis
Filliol, A. A., Farooq, M., Piquet‐Pellorce, C., Genêt, V., Dimanche‐Boitrel, M., Vandenabeele, P., Bertrand, M. J. M., Samson, M., & Seyec, J. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-09789-8 · Cited by 18
Berkhout, L. K., Barikbin, R., Schiller, B., Ravichandran, G., Krech, T., Neumann, K., Sass, G., & Tiegs, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-40324-z · Cited by 14
Chen, L., Cao, Z., Yan, L., Ding, Y., Shen, X., Liu, K., Xiang, X., Xie, Q., Zhu, C., Bao, S., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00526 · Cited by 14
Nuclear factor κB and hepatitis C—is there a connection?
Yen, B. T. S. (2000) · Hepatology · doi:10.1002/hep.510310334 · Cited by 11
Modeling fatty liver disease in animals: Is there an optimal approach, and is the effort worthwhile?
Maher, J. J. (2016) · Hepatology · doi:10.1002/hep.28823 · Cited by 11
Zhou, H., Yu, M., Roychowdhury, S., Sanz‐García, C., Pollard, K. A., McMullen, M. R., Liu, X., Li, X., & Nagy, L. E. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13345 · Cited by 10
NLRP3 receptor contributes to protection against experimental antigen-mediated cholangitis
González, M. I., Vannan, D. T., Eksteen, B., & Reyes, J. L. (2020) · Bioscience Reports · doi:10.1042/bsr20200689 · Cited by 9
Han, L., Teng, Y., Fan, Y., Gao, S., Li, F., & Wang, K. (2019) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.247.237 · Cited by 8
Dara, L., & Kaplowitz, N. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch54 · Cited by 8
Self-citationA new route to apoptosis in hepatitis C virus infection
Muratori, L., & Gibellini, D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00244-6 · Cited by 6
Cited by
NLRP3 inflammasome in cancer and metabolic diseases
Sharma, B. R., & Kanneganti, T.-D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00886-5 · Cited by 1,097
The multifaceted role of ferroptosis in liver disease
Chen, J., Li, X., Ge, C., Min, J., & Wang, F. (2022) · Cell Death & Differentiation · doi:10.1038/s41418-022-00941-0 · Cited by 665
Xu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 359
Mitochondria-associated programmed cell death as a therapeutic target for age-related disease
Nguyen, T. T., Wei, S., Nguyen, T. H., Jo, Y., Zhang, Y., Park, W., Gariani, K., Oh, C.-M., Kim, H. H., Ha, K.-T., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01046-5 · Cited by 325
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207
Metadata
- Authors
- Shojaie, L., Iorga, A., & Dara, L.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-12-18
- Volume
- 21
- Issue
- 24
- Pages
- 9682
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3110927546
- Cited by
- 293
- References
- 270
- FWCI
- 10.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.